Disease-based antimicrobial stewardship: a review of active and passive approaches to patient management
- PMID: 29177489
- DOI: 10.1093/jac/dkx266
Disease-based antimicrobial stewardship: a review of active and passive approaches to patient management
Abstract
Although new antimicrobial stewardship programmes (ASPs) often begin by targeting the reduction of antimicrobial use, an increasing focus of ASPs is to improve the management of specific infectious diseases. Disease-based antimicrobial stewardship emphasizes improving patient outcomes by optimizing antimicrobial use and increasing compliance with performance measures. Directing efforts towards the comprehensive management of specific infections allows ASPs to promote the shift in healthcare towards improving quality, safety and patient outcome metrics for specific diseases. This review evaluates published active and passive disease-based antimicrobial stewardship interventions and their impact on antimicrobial use and associated patient outcomes for patients with pneumonia, acute bacterial skin and skin structure infections, bloodstream infections, urinary tract infections, asymptomatic bacteriuria, Clostridium difficile infection and intra-abdominal infections. Current literature suggests that disease-based antimicrobial stewardship effects on medical management and patient outcomes vary based on infectious disease syndrome, resource availability and intervention type.
© The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Similar articles
-
Impact of an Antimicrobial Stewardship Care Bundle to Improve the Management of Patients with Suspected or Confirmed Urinary Tract Infection.Infect Control Hosp Epidemiol. 2016 Dec;37(12):1499-1501. doi: 10.1017/ice.2016.199. Epub 2016 Aug 30. Infect Control Hosp Epidemiol. 2016. PMID: 27573368
-
Feasibility and applicability of antimicrobial stewardship in immunocompromised patients.Curr Opin Infect Dis. 2017 Aug;30(4):346-353. doi: 10.1097/QCO.0000000000000380. Curr Opin Infect Dis. 2017. PMID: 28542093 Review.
-
A Multifaceted Antimicrobial Stewardship Program for the Treatment of Uncomplicated Cystitis in Nursing Home Residents.JAMA Intern Med. 2020 Jul 1;180(7):944-951. doi: 10.1001/jamainternmed.2020.1256. JAMA Intern Med. 2020. PMID: 32391862 Free PMC article. Clinical Trial.
-
An institutional review of antimicrobial stewardship interventions.J Glob Antimicrob Resist. 2016 Sep;6:75-77. doi: 10.1016/j.jgar.2016.03.006. Epub 2016 May 4. J Glob Antimicrob Resist. 2016. PMID: 27530844
-
Scottish Antimicrobial Prescribing Group (SAPG): development and impact of the Scottish National Antimicrobial Stewardship Programme.Int J Antimicrob Agents. 2011 Jul;38(1):16-26. doi: 10.1016/j.ijantimicag.2011.02.005. Epub 2011 Apr 22. Int J Antimicrob Agents. 2011. PMID: 21515030 Review.
Cited by
-
Antibiotic Stewardship in Surgical Departments.Antibiotics (Basel). 2024 Apr 4;13(4):329. doi: 10.3390/antibiotics13040329. Antibiotics (Basel). 2024. PMID: 38667005 Free PMC article. Review.
-
Antimicrobial utilization and stewardship in patients with uncomplicated urinary tract infections managed by pharmacists in the community: A sub-study of the RxOUTMAP trial.J Assoc Med Microbiol Infect Dis Can. 2021 Sep 30;6(3):205-212. doi: 10.3138/jammi-2020-0047. eCollection 2021 Sep. J Assoc Med Microbiol Infect Dis Can. 2021. PMID: 36337761 Free PMC article.
-
Factors influencing receipt of an antibiotic prescription among insured patients in Tanzania: a cross-sectional study.BMJ Open. 2022 Nov 4;12(11):e062147. doi: 10.1136/bmjopen-2022-062147. BMJ Open. 2022. PMID: 36332955 Free PMC article.
-
Stemming the Rise of Antibiotic Use for Community-Acquired Acute Respiratory Infections during COVID-19 Pandemic.Antibiotics (Basel). 2022 Jun 24;11(7):846. doi: 10.3390/antibiotics11070846. Antibiotics (Basel). 2022. PMID: 35884100 Free PMC article.
-
Impact of an electronic alert on prescription patterns of meropenem, voriconazole and caspofungin.BMC Infect Dis. 2021 Dec 20;21(1):1263. doi: 10.1186/s12879-021-06980-1. BMC Infect Dis. 2021. PMID: 34930162 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
